Cargando…
The Aβ Containing Brain Extracts Having Different Effects in Alzheimer’s Disease Transgenic Caenorhabditis elegans and Mice
Background: The deposition of β-sheet rich amyloid in senile plaques is a pathological hallmark of Alzheimer’s disease (AD), which is thought to cause neuronal dysfunction. Previous studies have strongly implicated that intracerebral infusion of brain extract containing aggregated β-amyloid (Aβ) is...
Autores principales: | Yang, Yufang, Wang, Mo, Yang, Ping, Wang, Zishan, Huang, Li, Xu, Jing, Wang, Wei, Yu, Mei, Bu, Liping, Fei, Jian, Huang, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079246/ https://www.ncbi.nlm.nih.gov/pubmed/30108498 http://dx.doi.org/10.3389/fnagi.2018.00208 |
Ejemplares similares
-
Metabolic profiling of a transgenic Caenorhabditis elegans Alzheimer model
por: Van Assche, Roel, et al.
Publicado: (2014) -
Autophagy Regulation Influences β-Amyloid Toxicity in Transgenic Caenorhabditis elegans
por: Lin, Hongru, et al.
Publicado: (2022) -
Neuroprotective Effects of Oligosaccharides in Rehmanniae Radix on Transgenic Caenorhabditis elegans Models for Alzheimer’s Disease
por: Kang, Nianxin, et al.
Publicado: (2022) -
Natural Bioactive Products and Alzheimer’s Disease Pathology: Lessons from Caenorhabditis elegans Transgenic Models
por: Navarro-Hortal, María D., et al.
Publicado: (2022) -
Modeling Alzheimer’s Disease in Caenorhabditis elegans
por: Alvarez, Javier, et al.
Publicado: (2022)